Mutation status of refractory to imatinib patients with chronic myeloid leukemia

Mutation status of refractory to imatinib patients with chronic myeloid leukemia

Mutation status of 36 chronic myeloid leukemia (CML) patients in chronic phase with primary and secondary imatinib resistance was analyzed. BCR-ABL mutations identified by direct DNA sequencing. BCR-ABL kinase domain mutations were detected in 30.5 % (11 of 36) of those patients. Most of identified...

תיאור מלא

מידע ביבליוגרפי
Main Authors: E. G. Ovsyannikova, K. D. Kaplanov, T. Yu. Klitochenko, A. V. Misyurin, I. L. Davydkin, L. V. Zaklyakova, E. A. Popov, B. N. Levitan
פורמט: Article
שפה:Russian
יצא לאור: ABV-press 2014-07-01
סדרה:Онкогематология
נושאים:
chronic myeloid leukemia
bcr-abl mutations
resistance
imatinib
גישה מקוונת:https://oncohematology.abvpress.ru/ongm/article/view/72

אינטרנט

https://oncohematology.abvpress.ru/ongm/article/view/72

פריטים דומים